Study Reviews

EPA and DHA reduce the frequency of seizures in drug-resistant epilepsy

  • 10/31/2018

Eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) play important roles in the maintenance and modulation of neuron functions, and there is evidence that they have anticonvulsant effects. On this basis, research was conducted on...

Read more


The positive effects of rapamycin are strengthened and its side effects minimised by association with omega-3 PUFA

  • 10/25/2018

Breast cancer is the second leading cause of cancer death among women. Hormone therapy significantly increases survival in women with this type of cancer, but it is not effective in patients with triple-negative breast cancer (breast...

Read more


The positive effects of rapamycin are strengthened and its side effects minimised by association with omega-3 PUFA

  • 10/24/2018

Breast cancer is the second leading cause of cancer death among women. Hormone therapy significantly increases survival in women with this type of cancer, but it is not effective in patients with triple-negative breast cancer (breast...

Read more


New information on the importance of DHA in brain development

  • 10/16/2018

The brain is one of the most lipid-rich organs in the body. Docosahexaenoic acid (DHA) is found in large amounts in brain phospholipids, particularly phosphatidylethanolamine, phosphatidylserine and phosphatidylcholine, and constitutes...

Read more


Omega-3 supplementation before Roux-en-Y gastric bypass

  • 10/10/2018

Obesity is one of the most serious health problems in the world today and is considered a global epidemic (it is the second leading avoidable cause of death after smoking) by the World Health Organisation. The Roux-en-Y gastric bypass is a...

Read more


The omega-3 index appears to be associated with physical function in the elderly

  • 10/03/2018

A group of researchers from the University of Toulouse (France) recently published the results from a study whose aim was to analyse possible associations between omega-3 polyunsaturated fatty acid (PUFA) status, measured using the omega-3...

Read more


Omega-3 reduces discomfort produced by contact lenses

  • 10/01/2018

A controlled, randomised trial was carried out on 72 adults with inflammation associated with discomfort from contact lenses to assess whether the anti-inflammatory therapeutic strategy (topical corticosteriods and omega-3 fatty acid...

Read more


The importance of taking omega 6 into consideration when assessing the effects of omega 3 on myocardial infarction

  • 09/28/2018

Experimentally, omega-3 polyunsaturated fatty acids (PUFAs) have been shown to have beneficial cardiovascular effects, including reducing the myocardial infarct size. However, results from recent clinical trials suggest a lesser role for...

Read more


Omega-3 PUFA supplementation provides beneficial effects on cardiometabolic markers and glycaemic control in diabetes mellitus type 2

  • 09/17/2018

Cardiovascular disease is the main cause of morbidity and mortality in people with diabetes mellitus type 2 (DMT2) and glycaemic control, the key objective in antidiabetic control, only has a marginal effect on cardiovascular risk. However...

Read more


High EPA plasma levels are associated with a lower risk of Alzheimer’s disease

  • 09/13/2018

The neuroprotective properties of polyunsaturated fatty acids (PUFAs) are well established (especially for docosahexaenoic acid (DHA)) and there is growing evidence to support its protective effect in Alzheimer’s disease. The 2018...

Read more

Pages

CATEGORIES

ARCHIVE